Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...
M&A markets don't like volatility and unpredictability, and what we've seen in the past few weeks is the opposite of that,” ...
The acquisition of Anthos Therapeutics could be worth up to $3.1 billion and returns to Novartis a blood thinner it licensed ...
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,03,909.10 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...